Antimutagenic compounds and their possible mechanisms of action

Journal of Applied Genetics

Volumn 55, Issue 2, 2014, Pages 273-285

  Słoczyńska, Karolina ^a   Powroźnik, Beata ^a   Pekala, Elzbieta ^a   Waszkielewicz, Anna M ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antimutagen; Antimutagenicity; DNA damage; Mutagen; Mutagenicity

Indexed keywords

2 AMINOANTHRACENE; 2 FLUORENYLAMINE; ACRIDINE; AFLATOXIN B1; AMINOACRIDINE; AMINOKETONE; ANTIMUTAGENIC AGENT; CYCLOPHOSPHAMIDE; CYSTEINE; DOXORUBICIN; FLAVONE DERIVATIVE; GALLIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LUTEOLIN; MANGIFERA INDICA EXTRACT; MESYLIC ACID ETHYL ESTER; METHYLNITRONITROSOGUANIDINE; N (2 FLUORENYL) ACETAMIDE; SODIUM AZIDE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE; ANTIOXIDANT; MUTAGENIC AGENT;

ACACIA; ACANTHOPANAX; ANTIOXIDANT ACTIVITY; CANCER RESEARCH; DNA DAMAGE; DNA REPLICATION; DNA SEQUENCE; DRUG MECHANISM; ELECTROPHILICITY; ESCHERICHIA COLI; GENE MUTATION; GENOTOXICITY; METABOLIC ACTIVATION; MICRONUCLEUS TEST; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PHELLINUS; REVIEW; SACCHAROMYCES CEREVISIAE; SALMONELLA TYPHIMURIUM; STRUCTURAL CHROMOSOME ABERRATION; VIBRIO HARVEYI; WHEAT BRAN; ANIMAL; DRUG SCREENING; HUMAN;

ANIMALS; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; DRUG EVALUATION, PRECLINICAL; HUMANS; MUTAGENICITY TESTS; MUTAGENS;

EID: 84899410793     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-014-0198-9     Document Type: Review

References (112)

1. Achary VMM, Panda BB (2010) Aluminium-induced DNA damage and adaptive response to genotoxic stress in plant cells are mediated through reactive oxygen intermediates. Mutagenesis 25: 201-209.
2. Agar G, Gulluce M, Aslan A, Bozari S, Karadayi M, Orhan F (2010) Mutation preventive and antigenotoxic potential of methanol extracts of two natural lichen. J Med Plant Res 4: 2132-2137.
3. Ajith TA, Janardhanan KK (2011) Antimutagenic effect of Phellinus rimosus (Berk) Pilat against chemical induced mutations of histidine dependent Salmonella typhimurium strains. Food Chem Toxicol 49: 2676-2680.
4. Alpsoy L, Yildirim A, Agar G (2009) The antioxidant effects of vitamin A, C, and E on aflatoxin B1-induced oxidative stress in human lymphocytes. Toxicol Ind Health 25: 121-127.
5. Al-Qurainy F, Khan S (2009) Mutagenic effects of sodium azide and its application in crop improvement. World Appl Sci J 6: 1589-1601.
6. Bacolod MD, Basu AK (2001) Mutagenicity of a single 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-yl)-1-aminopyrene in Escherichia coli located in a GGC sequence. Mutagenesis 16: 461-465.
7. Beranek DT (1990) Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res 231: 11-30.
8. Beudot C, De Méo MP, Dauzonne D, Elias R, Laget M, Guiraud H, Balansard G, Duménil G (1998) Evaluation of the mutagenicity and antimutagenicity of forty-two 3-substituted flavones in the Ames test. Mutat Res 417: 141-153.
9. Boubaker J, Mansour HB, Ghedira K, Chekir-Ghedira L (2011) Antimutagenic and free radical scavenger effects of leaf extracts from Accacia salicina. Ann Clin Microbiol Antimicrob 10: 37. doi: 10. 1186/1476-0711-10-37.
10. Burlinson B (2012) The in vitro and in vivo comet assays. Methods Mol Biol 817: 143-163.
11. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, Escobar P, Honma M, Kumaravel TS, Nakajima M, Sasaki YF, Thybaud V, Uno Y, Vasquez M, Hartmann A; In vivo Comet Assay Workgroup, part of the Fourth International Workgroup on Genotoxicity Testing (2007) Fourth international workgroup on genotoxicity testing: results of the in vivo comet assay workgroup. Mutat Res 627: 31-35.
12. 2 in IPEC-J2 cells. Mol Cell Biochem 378: 73-81.
13. Chatti IB, Boubaker J, Skandrani I, Bhouri W, Ghedira K, Chekir Ghedira L (2011) Antioxidant and antigenotoxic activities in Acacia salicina extracts and its protective role against DNA strand scission induced by hydroxyl radical. Food Chem Toxicol 49: 1753-1758.
14. Collins AR, Azqueta A, Langie SA (2012) Effects of micronutrients on DNA repair. Eur J Nutr 51: 261-279.
15. Combes R, Grindon C, Cronin MT, Roberts DW, Garrod J (2007) Proposed integrated decision-tree testing strategies for mutagenicity and carcinogenicity in relation to the EU REACH legislation. Altern Lab Anim 35: 267-287.
16. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17: 1195-1214.
17. Czyż A, Jasiecki J, Bogdan A, Szpilewska H, We{ogonek}grzyn G (2000) Genetically modified Vibrio harveyi strains as potential bioindicators of mutagenic pollution of marine environments. Appl Environ Microbiol 66: 599-605.
18. Czyż A, Szpilewska H, Dutkiewicz R, Kowalska W, Biniewska-Godlewska A, We{ogonek}grzyn G (2002) Comparison of the Ames test and a newly developed assay for detection of mutagenic pollution of marine environments. Mutat Res 519: 67-74.
19. DeBaun JR, Smith JYR, Miller EC, Miller JA (1970) Reactivity in vivo of the carcinogen N-hydroxy-2-acetylaminofluorene: increase by sulfate ion. Science 167: 184-186.
20. De Flora S (1998) Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat Res 402: 151-158.
21. De Flora S, Bronzetti G, Sobels FH (1992) Assessment of antimutagenicity and anticarcinogenicity. Mutat Res 267: 153-155.
22. De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, Albini A (2001) Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res 480-481: 9-22.
23. de Oliveira APS, de Sousa JF, da Silva MA, Hilário F, Resende FA, de Camargo MS, Vilegas W, dos Santos LC, Varanda EA (2013) Estrogenic and chemopreventive activities of xanthones and flavones of Syngonanthus (Eriocaulaceae). Steroids 78: 1053-1063.
24. Dion ME, Agler M, Milner JA (1997) S-allyl cysteine inhibits nitrosomorpholine formation and bioactivation. Nutr Cancer 28: 1-6.
25. Eadie JS, Conrad M, Toorchen D, Topal MD (1984) Mechanism of mutagenesis by O6-methylguanine. Nature 308: 201-203.
26. Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, Douglas GR, Nohmi T, Phillips DH, Vickers C (2009) Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme. Mutagenesis 24: 341-349.
27. El-Sayed WM, Hussin WA (2013) Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2, 2′-bichalcophenes and aza-analogs. Drug Des Dev Ther 7: 73-81.
28. El-Sayed WM, Hussin WA, Al-Faiyz YS, Ismail MA (2013) The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1, 2-a]pyridine derivatives. Eur J Pharmacol 715: 212-218.
29. Evans JL, Goldfine ID (2000) Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2: 401-413.
30. Ferguson LR, Denny WA (2007) Genotoxicity of non-covalent interactions: DNA intercalators. Mutat Res 623: 14-23.
31. Ferguson LR, Philpot M (2008) Nutrition and mutagenesis. Annu Rev Nutr 28: 313-329.
32. Frassinetti S, Della Croce CM, Caltavuturo L, Longo V (2012) Antimutagenic and antioxidant activity of Lisosan G in Saccharomyces cerevisiae. Food Chem 135: 2029-2034.
33. Fronza G, Campomenosi P, Iannone R, Abbondandolo A (1992) The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions. Nucleic Acids Res 20: 1283-1287.
34. Gill JP, Romano LJ (2005) Mechanism for N-acetyl-2-aminofluorene-induced frameshift mutagenesis by Escherichia coli DNA polymerase I (Klenow fragment). Biochemistry 44: 15387-15395.
35. Guha B, Khuda-Bukhsh AR (2003) Ameliorating effect of beta-carotene on ethylmethane sulphonate-induced genotoxicity in the fish Oreochromis mossambicus. Mutat Res 542: 1-13.
36. Gulluce M, Agar G, Baris O, Karadayi M, Orhan F, Sahin F (2010) Mutagenic and antimutagenic effects of hexane extract of some Astragalus species grown in the eastern Anatolia region of Turkey. Phytother Res 24: 1014-1018.
37. Hamilton SM, Teel RW (1995) Effects of isothiocyanates on cytochrome P-450 1A1 and 1A2 activity and on the mutagenicity of heterocyclic amines. Anticancer Res 16: 3597-3602.
38. Heo MY, Sohn SJ, Au WW (2001) Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488: 135-150.
39. Hoffmann GR, Calciano MA, Lawless BM, Mahoney KM (2003) Frameshift mutations induced by three classes of acridines in the lacZ reversion assay in Escherichia coli: potency of responses and relationship to slipped mispairing models. Environ Mol Mutagen 42: 111-121.
40. Hong CE, Cho MC, Jang HA, Lyu SY (2011) Mutagenicity and anti-mutagenicity of Acanthopanax divaricatus var. albeofructus. J Toxicol Sci 36: 661-668.
41. Hour TC, Liang YC, Chu IS, Lin JK (1999) Inhibition of eleven mutagens by various tea extracts, (-)epigallocatechin-3-gallate, gallic acid and caffeine. Food Chem Toxicol 37: 569-579.
42. Ikken Y, Morales P, Martínez A, Marín ML, Haza AI, Cambero MI (1999) Antimutagenic effect of fruit and vegetable ethanolic extracts against N-nitrosamines evaluated by the Ames test. J Agric Food Chem 47: 3257-3264.
43. Izzotti A, Saccà SC, Cartiglia C, De Flora S (2003) Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 114: 638-646.
44. Johnson GE (2012) Mammalian cell HPRT gene mutation assay: test methods. Methods Mol Biol 817: 55-67.
45. Kada T, Shimoi K (1987) Desmutagens and bio-antimutagens-their modes of action. Bioessays 7: 113-116.
46. Kada T, Inoue T, Namiki N (1982) Environmental desmutagens and antimutagens. In: Klekowski EJ (ed) Environmental mutagenesis and plant biology. Praeger, New York, pp 137-151.
47. Kamiński K, Obniska J, Chlebek I, Liana P, Pe{ogonek}kala E (2013) Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3, 3-dimethyl-succinimides. Part V. Eur J Med Chem 66: 12-21.
48. Kaur S, Kumar S, Kaur P, Chandel M (2010) Study of antimutagenic potential of phytoconstituents isolated from Terminalia arjuna in the Salmonella/microsome assay. Am J Biomed Sci 2: 164-177.
49. Koch WH, Henrikson EN, Kupchella E, Cebula TA (1994) Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity. Carcinogenesis 15: 79-88.
50. 1 in human lymphocytes in vitro. Toxicol Ind Health 27: 599-605.
51. Kumaresan KR, Springhorn SS, Lacks SA (1995) Lethal and mutagenic actions of N-methyl-N′-nitro-Nnitrosoguanidine potentiated by oxidized glutathione, a seemingly harmless substance in the cellular environment. J Bacteriol 177: 3641-3646.
52. Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11: 211-218.
53. Lewis SE, Barnett LB, Felton C, Johnson FM, Skow LC, Cacheiro N, Shelby MD (1986) Dominant visible and electrophoretically expressed mutations induced in male mice exposed to ethylene oxide by inhalation. Environ Mutagen 8: 867-872.
54. Marnewick JL, Gelderblom WCA, Joubert E (2000) An investigation on the antimutagenic properties of South African herbal teas. Mutat Res 471: 157-166.
55. Maron DM, Ames BN (1983) Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173-215.
56. Maurici D, Aardema M, Corvi R, Kleber M, Krul C, Laurent C, Loprieno N, Pasanen M, Pfuhler S, Phillips B, Sabbioni E, Sanner T, Vanparys P (2005) Genotoxicity and mutagenicity. Altern Lab Anim 33(Suppl 1): 117-130.
57. Migliore L, Coppedè F (2002) Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512: 135-153.
58. Morffi J, Rodeiro I, Hernández SL, González L, Herrera J, Espinosa-Aguirre JJ (2012) Antimutagenic properties of Mangifera indica L. stem bark extract and evaluation of its effects on hepatic CYP1A1. Plant Foods Hum Nutr 67: 223-228.
59. Mortelmans K, Riccio ES (2000) The bacterial tryptophan reverse mutation assay with Escherichia coli WP2. Mutat Res 455: 61-69.
60. Mortelmans K, Zeiger E (2000) The Ames Salmonella/microsome mutagenicity assay. Mutat Res 455: 29-60.
61. Nardemir G, Yanmis D, Alpsoy L, Gulluce M, Agar G, Aslan A (2013) Genotoxic, antigenotoxic and antioxidant properties of methanol extracts obtained from Peltigera horizontalis and Peltigera praetextata. Toxicol Ind Health. 2013 Mar 1 [Epub ahead of print].
62. Novick A, Szilard L (1952) Anti-mutagens. Nature 170: 926-927.
63. Organisation for Economic Co-operation and Development (OECD) (1984) Genetic toxicology: rodent dominant lethal test. Test Guideline 478, OECD, Paris.
64. Organisation for Economic Co-operation and Development (OECD) (1986a) Genetic toxicology: Saccharomyces cerevisiae, gene mutation assay. Test Guideline 480, OECD, Paris.
65. Organisation for Economic Co-operation and Development (OECD) (1986b) Genetic toxicology: mouse heritable translocation assay. Test Guideline 485, OECD, Paris.
66. Organisation for Economic Co-operation and Development (OECD) (1997a) Bacterial reverse mutation test. Test Guideline 471, OECD, Paris.
67. Organisation for Economic Co-operation and Development (OECD) (1997b) In vitro mammalian chromosome aberration test. Test Guideline 473, OECD, Paris.
68. Organisation for Economic Co-operation and Development (OECD) (1997c) Mammalian erythrocyte micronucleus test. Test Guideline 474, OECD, Paris.
69. Organisation for Economic Co-operation and Development (OECD) (1997d) Mammalian bone marrow chromosome aberration test. Test Guideline 475, OECD, Paris.
70. Organisation for Economic Co-operation and Development (OECD) (1997e) In vitro mammalian cell gene mutation test. Test Guideline 476, OECD, Paris.
71. Organisation for Economic Co-operation and Development (OECD) (1997f) Mammalian spermatogonial chromosome aberration test. Test Guideline 483, OECD, Paris.
72. Organisation for Economic Co-operation and Development (OECD) (1997g) Unscheduled DNA synthesis (UDS) test with mammalian liver cells in vivo. Test Guideline 486, OECD, Paris.
73. Organisation for Economic Co-operation and Development (OECD) (2010) In vitro mammalian cell micronucleus test. Test Guideline 487, OECD, Paris.
74. Orhan F, Gulluce M, Ozkan H, Alpsoy L (2013) Determination of the antigenotoxic potencies of some luteolin derivatives by using a eukaryotic cell system, Saccharomyces cerevisiae. Food Chem 141: 366-372.
75. Ozturkcan SA, Turhan K, Turgut Z, Karadayi M, Gulluce M (2012) Antigenotoxic properties of two newly synthesized β-aminoketones against N-methyl-N′-nitro-N-nitrosoguanidine and 9-aminoacridine-induced mutagenesis. J Biochem Mol Toxicol 26: 258-263.
76. Paolini M, Abdel-Rahman SZ, Sapone A, Pedulli GF, Perocco P, Cantelli-Forti G, Legator MS (2003) Beta-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 543: 195-200.
77. Parvathy KS, Negi PS, Srinivas P (2010) Curcumin-amino acid conjugates: synthesis, antioxidant and antimutagenic attributes. Food Chem 120: 523-530.
78. Pe{ogonek}kala E, Liana P, Kubowicz P, Powroźnik B, Obniska J, Chlebek I, We{ogonek}grzyn A, We{ogonek}grzyn G (2013) Evaluation of mutagenic and antimutagenic properties of new derivatives of pyrrolidine-2, 5-dione with anti-epileptic activity, by use of the Vibrio harveyi mutagenicity test. Mutat Res 758: 18-22.
79. Pesarini JR, Zaninetti PT, Mauro MO, Carreira CM, Dichi JB, Ribeiro LR, Mantovani MS, Oliveira RJ (2013) Antimutagenic and anticarcinogenic effects of wheat bran in vivo. Genet Mol Res 12: 1646-1659.
80. Piosik J, Ulanowska K, Gwizdek-Wiśniewska A, Czyż A, Kapuściński J, We{ogonek}grzyn G (2003) Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline. Mutat Res 530: 47-57.
81. Podgórska B, Che{ogonek}ć E, Ulanowska K, We{ogonek}grzyn G (2005) Optimisation of the microbiological mutagenicity assay based on genetically modified Vibrio harveyi strains. J Appl Genet 46: 241-246.
82. Quillardet P, Hofnung M (1985) The SOS chromotest, a colorimetric bacterial assay for genotoxins: procedures. Mutat Res 147: 65-78.
83. Quillardet P, de Bellecombe C, Hofnung M (1985) The SOS Chromotest, a colorimetric bacterial assay for genotoxins: validation study with 83 compounds. Mutat Res 147: 79-95.
84. Ralhan R, Kaur J (2007) Alkylating agents and cancer therapy. Expert Opin Ther Pat 17: 1061-1075.
85. Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C (2013) Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. Mol Nutr Food Res 57: 114-125.
86. Roy SS, Chakraborty P, Ghosh P, Ghosh S, Biswas J, Bhattacharya S (2012) Influence of novel naphthalimide-based organoselenium on genotoxicity induced by an alkylating agent: the role of reactive oxygen species and selenoenzymes. Redox Rep 17: 157-166.
87. Russell LB, Selby PB, von Halle E, Sheridan W, Valkovic L (1981) The mouse specific-locus test with agents other than radiations: interpretation of data and recommendations for future work. Mutat Res 86: 329-354.
88. Sanderson BJ, Shield AJ (1996) Mutagenic damage to mammalian cells by therapeutic alkylating agents. Mutat Res 355: 41-57.
89. Schwab CE, Huber WW, Parzefall W, Hietsch G, Kassie F, Schulte-Hermann R, Knasmüller S (2000) Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit Rev Toxicol 30: 1-69.
90. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 1790: 1149-1160.
91. Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N (2000) Adriamycin-induced heart failure: mechanisms and modulation. Mol Cell Biochem 207: 77-86.
92. Singer TM, Lambert IB, Williams A, Douglas GR, Yauk CL (2006) Detection of induced male germline mutation: correlations and comparisons between traditional germline mutation assays, transgenic rodent assays and expanded simple tandem repeat instability assays. Mutat Res 598: 164-193.
93. Słoczyńska K, Pe{ogonek}kala E, Wajda A, We{ogonek}grzyn G, Marona H (2010) Evaluation of mutagenic and antimutagenic properties of some bioactive xanthone derivatives using Vibrio harveyi test. Lett Appl Microbiol 50: 252-257.
94. Smith WA, Gupta RC (1996) Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Carcinogenesis 17: 1285-1290.
95. So M, Hvastkovs EG, Bajrami B, Schenkman JB, Rusling JF (2008) Electrochemical genotoxicity screening for arylamines bioactivated by N-acetyltransferase. Anal Chem 80: 1192-1200.
96. Sugamori KS, Brenneman D, Grant DM (2006) In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice. Am Soc Pharmacol Exp Ther 34: 1697-1702.
97. Tian YF, Hsieh CH, Hsieh YJ, Chen YT, Peng YJ, Hsieh PS (2012) α-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and β cell dysfunction. Eur J Clin Invest 42: 637-648.
98. Tsai SJ, Jeng SN, Lee H (1996) Naturally occurring diallyl disulfide inhibits the formation of carcinogenic heterocyclic aromatic amines in boiled pork juice. Mutagenesis 11: 235-240.
99. Turhan K, Ozturkcan SA, Turgut Z, Karadayi M, Gulluce M (2012) Protective properties of five newly synthesized cyclic compounds against sodium azide and N-methyl-N′-nitro-N-nitrosoguanidine genotoxicity. Toxicol Ind Health 28: 605-613.
100. Ulanowska K, We{ogonek}grzyn G (2006) Mutagenic activity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Appl Genet 47: 85-87.
101. Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, We{ogonek}grzyn G (2005) Formation of stacking complexes between caffeine (1, 2, 3-trimethylxanthine) and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine may attenuate biological effects of this neurotoxin. Bioorg Chem 33: 402-413.
102. Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, We{ogonek}grzyn G (2007) Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2, 3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines. Bioorg Med Chem 15: 5150-5157.
103. Unal F, Taner G, Yuzbasioglu D, Yilmaz S (2013) Antigenotoxic effect of lipoic acid against mitomycin-C in human lymphocyte cultures. Cytotechnology 65: 553-565.
104. Valdiglesias V, Pásaro E, Méndez J, Laffon B (2010) In vitro evaluation of selenium genotoxic, cytotoxic, and protective effects: a review. Arch Toxicol 84: 337-351.
105. Verhofstad N, Linschooten JO, van Benthem J, Dubrova YE, van Steeg H, van Schooten FJ, Godschalk RWL (2008) New methods for assessing male germ line mutations in humans and genetic risks in their offspring. Mutagenesis 23: 241-247.
106. von Borstel RC, Higgins JA (1998) Janus carcinogens and mutagens. Mutat Res 402: 321-329.
107. Watanabe M, Kobayashi H, Ohta T (1994) Rapid inactivation of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a potent mutagen in chlorinated drinking water, by sulfhydryl compounds. Mutat Res 312: 131-138.
108. Weakley SM, Jiang J, Kougias P, Lin PH, Yao Q, Brunicardi FC, Gibbs RA, Chen C (2010) Role of somatic mutations in vascular disease formation. Expert Rev Mol Diagn 10: 173-185.
109. We{ogonek}grzyn G, Czyż A (2003) Detection of mutagenic pollution of natural environment using microbiological assays. J Appl Microbiol 95: 1175-1181.
110. Zeiger E (2003) Illusions of safety: antimutagens can be mutagens, and anticarcinogens can be carcinogens. Mutat Res 543: 191-194.
111. Zhang J, Tian Q, Chan SY, Li SC, Zhou S, Duan W, Zhu YZ (2005) Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metab Rev 37: 611-703.
112. Zimmermann FK, Kern R, Rasenberg H (1975) A yeast strain for simultaneous detection of induced mitotic crossing over, mitotic gene conversion and reverse mutation. Mutat Res 28: 381-388.